All Stories

  1. Causal Uncertainty-Decomposed Ensemble Learning for Confounding-Aware Skin Cancer Detection in Dermoscopic Images
  2. Multiclass Machine Learning-Based Discovery of Novel Scaffold Inhibitors Targeting ALK
  3. Alginate-derived smart hydrogel dressing with CaP/ZnO synergy for on-demand hemostasis and pH-triggered curcumin delivery
  4. Catharanthus roseus Phytochemicals as Multi-Target Modulators of Disability-Linked Neurodegeneration: Bio-Computational Insights
  5. Network-based clustering and statistical evaluation to elucidate structure-activity relationships of EZH2 inhibitors
  6. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  7. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  8. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  9. Skeletal Muscle Aging: Enhancing Skeletal Muscle Integrity and Function as a Potential Pharmacological Approach
  10. The current scenario in cultured meat production and the challenges for industrialization
  11. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  12. Hydrogel-Integrated Biomimetic Hydroxyapatite Scaffolds with Tunable Porosity for Enhanced Curcumin Delivery
  13. Explainable Artificial Intelligence: A Perspective on Drug Discovery
  14. Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis
  15. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  16. Machine Learning-Driven Consensus Modeling for Activity Ranking and Chemical Landscape Analysis of HIV-1 Inhibitors
  17. Large Language Models in Genomics—A Perspective on Personalized Medicine
  18. Development of multifunctional PAA-alginate-carboxymethyl cellulose hydrogel-loaded fiber-reinforced biomimetic scaffolds for controlled release of curcumin
  19. Biomimetic design and fabrication of hydroxyapatite bone scaffolds with controllable interconnected pores via modified direct foaming method
  20. Transforming Pest Management with Artificial Intelligence Technologies: The Future of Crop Protection
  21. AI in infectious disease diagnosis and vaccine development
  22. Deciphering the Anti-Autism Potential of Withania somnifera Phytochemicals Targeting SLC6A4 Through Computational Approaches
  23. Global, Regional, and National Trends in Routine Childhood Vaccination Coverage From 1980 to 2023 With Forecasts to 2030: A Systematic Analysis for the Global Burden of Disease Study 2023
  24. Biological insights and therapeutic potential of Glycyrrhiza uralensis and its bioactive compounds: an updated review
  25. Artificial General Intelligence for the Detection of Neurodegenerative Disorders
  26. Molecular Landscape of Bladder Cancer: Key Genes, Transcription Factors, and Drug Interactions
  27. Editorial: Research and developments in cultured meat production
  28. Therapeutic potential and action mechanisms of licochalcone B: a mini review
  29. Effect of Glycyrrhiza uralensis crude water extract on the expression of Nitric Oxide Synthase 2 gene during myogenesis
  30. Editorial: Computational drug discovery of medicinal compounds for cancer management, volume II
  31. Therapeutic applications of biological macromolecules and scaffolds for skeletal muscle regeneration: A review
  32. Licochalcone A and B enhance muscle proliferation and differentiation by regulating Myostatin
  33. Targeting myostatin using quercetin as a media supplement to improve myogenesis for cultured meat production: An in silico and in vitro study
  34. Identification of active compounds as novel dipeptidyl peptidase-4 inhibitors through machine learning and structure-based molecular docking simulations
  35. Therapeutic Applications of Ginseng Natural Compounds for Health Management
  36. Editorial: Computational drug discovery of medicinal compounds for cancer management
  37. natural compounds for skeletal muscle-associated metabolic disorders
  38. Extracellular matrix and skeletal muscle regeneration
  39. Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
  40. Potential of Natural Phenolic Compounds as Antimicrobial Agents against Multidrug-Resistant Staphylococcus aureus in Chicken Meat
  41. Mss51 protein inhibition serves as a novel target for type 2 diabetes: a molecular docking and simulation study
  42. Therapeutic applications of ginseng for skeletal muscle-related disorder management
  43. Editorial: An insight into multi-omics analysis of dementia disorders
  44. Editorial: Impact of hyperglycemia induced oxidative stress in genetics and epigenetics of metabolic diseases
  45. The roles of growth factors and hormones in the regulation of muscle satellite cells for cultured meat production
  46. IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation
  47. Dipeptidyl peptidase-4 inhibitory potentials of Glycyrrhiza uralensis and its bioactive compounds licochalcone A and licochalcone B: An in silico and in vitro study
  48. Editorial: Unfolded protein response (UPR): An impending target for multiple neurological disorders
  49. Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
  50. Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
  51. Biocomputational Assessment of Natural Compounds as a Potent Inhibitor to Quorum Sensors in Ralstonia solanacearum
  52. Molecular Mechanisms and Current Treatment Options for Cancer Cachexia
  53. MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
  54. Extracellular Matrix and the Production of Cultured Meat
  55. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
  56. Fruit Derived Potentially Bioactive Bioengineered Silver Nanoparticles
  57. Cell Types Used for Cultured Meat Production and the Importance of Myokines
  58. Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy
  59. Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
  60. Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid Accumulation
  61. Halotolerant Microbial Consortia for Sustainable Mitigation of Salinity Stress, Growth Promotion, and Mineral Uptake in Tomato Plants and Soil Nutrient Enrichment
  62. A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
  63. Biocomputational Screening of Natural Compounds against Acetylcholinesterase
  64. Identification of Novel FNIN2 and FNIN3 Fibronectin-Derived Peptides That Promote Cell Adhesion, Proliferation and Differentiation in Primary Cells and Stem Cells
  65. IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
  66. Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs
  67. Isolation and Characterization of Compounds from Glycyrrhiza uralensis as Therapeutic Agents for the Muscle Disorders
  68. Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes
  69. Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases
  70. Skeletal Muscle Extracellular Matrix: Composition, Structure and Function
  71. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases
  72. Implications of Skeletal Muscle Extracellular Matrix Remodeling in Metabolic Disorders: Diabetes Perspective
  73. Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
  74. Cross-Talk Between Extracellular Matrix and Skeletal Muscle: Implications for Myopathies
  75. N-Acetylaspartate Is an Important Brain Osmolyte
  76. Understanding Calcium-Dependent Conformational Changes in S100A1 Protein: A Combination of Molecular Dynamics and Gene Expression Study in Skeletal Muscle
  77. An insight into molecular interaction of PGIP with PG for banana cultivar
  78. Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M pro
  79. Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro
  80. Transthyretin Maintains Muscle Homeostasis Through the Novel Shuttle Pathway of Thyroid Hormones During Myoblast Differentiation
  81. Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges
  82. Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance
  83. Targeting Caspase 8: Using Structural and Ligand-Based Approaches to Identify Potential Leads for the Treatment of Multi-Neurodegenerative Diseases
  84. Subtractive genomics approach for identification of putative antimicrobial targets in Xanthomonas oryzae pv. oryzae KACC10331
  85. Dermatopontin in Skeletal Muscle Extracellular Matrix Regulates Myogenesis
  86. Lead Optimization Resources in Drug Discovery for Diabetes
  87. Efficacy of a novel bacteriocin isolated from Lysinibacillus sp. against Bacillus pumilus
  88. Multi-Spectroscopic Characterization of Human Serum Albumin Binding with Cyclobenzaprine Hydrochloride: Insights from Biophysical and In Silico Approaches
  89. NeuroMuscleDB: a Database of Genes Associated with Muscle Development, Neuromuscular Diseases, Ageing, and Neurodegeneration
  90. Protein modeling, molecular network and molecular dynamics study of newly sequenced interleukin-18 (IL-18) gene in Mus musculus
  91. Computational Analysis of Protein–Protein Interactions in Motile T-Cells
  92. Biogenic pentagonal silver nanoparticles for safer and more effective antibacterial therapeutics
  93. A complex relationship between extracellular matrix, insulin resistance, and skeletal muscle
  94. Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies
  95. A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
  96. Novel insight into the molecular interaction of catalase and sucrose: A combination of in silico and in planta assays study
  97. ADNCD: a compendious database on anti-diabetic natural compounds focusing on mechanism of action
  98. Protein-protein Interactions and their Role in Various Diseases and their Prediction Techniques
  99. Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
  100. Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders
  101. Role of Azoles in Cancer Prevention and Treatment: Present and Future Perspectives
  102. Binding of Tolperisone Hydrochloride with Human Serum Albumin: Effects on the Conformation, Thermodynamics, and Activity of HSA
  103. Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
  104. Fibromodulin and regulation of the intricate balance between myoblast differentiation to myocytes or adipocyte-like cells
  105. Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy
  106. Do all roads lead to the Rome? The glycation perspective!
  107. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview
  108. Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
  109. Gymnema sylvestre for Diabetes: From Traditional Herb to Future’s Therapeutic
  110. Genome-wide comparative analysis of codon usage bias and codon context patterns among cyanobacterial genomes
  111. Identification of common therapeutic targets for selected neurodegenerative disorders: An in silico approach
  112. Computer Aided Drug Design: Success and Limitations
  113. Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds
  114. Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: MultiscoringIn SilicoApproach
  115. Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches
  116. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: Its potential role in prompt recognition of diabetes mellitus auto-antibodies
  117. Molecular Interaction of Acetylcholinesterase with Carnosic Acid Derivatives: A Neuroinformatics Study
  118. Structure based molecular inhibition of Caspase-8 for treatment of multi-neurodegenerative diseases using known natural compounds
  119. Protease characteristics of bacteriocin producing Lysinibacilli, isolated from fruits and vegetable waste
  120. Drug Discovery and In Silico Techniques: A Mini-Review
  121. Predicted binding of certain antifilarial compounds with glutathione-S-transferase of human Filariids
  122. Mapping and analysis of the LINE and SINE type of repetitive elements in rice